Thanks! You've successfully subscribed to the BONEZONE®/OMTEC® Monthly eNewsletter!

Please take a moment to tell us more about yourself and help us keep unwanted emails out of your inbox.

Choose one or more mailing lists:
BONEZONE/OMTEC Monthly eNewsletter
OMTEC Conference Updates
Advertising/Sponsorship Opportunities
Exhibiting Opportunities
* Indicates a required field.

Tecomet Appoints Victor Swint as CEO

                Victor Swint

Tecomet named Victor Swint as its new President and Chief Executive Officer, replacing Bill Dow who served as interim CEO since September 2018. Mr. Dow remains the chairman of Tecomet's board.

Mr. Swint has more than 20 years of experience at various manufacturing organizations and a variety of industries. He joins Tecomet from Interface Performance Materials, where he was CEO. He was previously a Group President at Illinois Tool Works, a Vice President and General Manager at Rockwell Automation and has also held managerial roles at Cooper Industries and Danaher. He earned a B.S. in Economics from the University of Maryland and an MBA from Harvard Business School. 

“Victor’s breadth of manufacturing experience and his ability to align teams and resources to drive change will be invaluable to the strategic direction of Tecomet and its future performance,” Mr. Dow said in a press release.

Tecomet—which operates 17 global manufacturing facilities in five countries and employs over 3,000 people—specializes in forged, cast and machined orthopaedic implants, precision surgical instruments, sterilization cases/trays and photochemical etched products.

ORTHOWORLD® estimates that Tecomet is the largest contract manufacturer serving the orthopaedic industry..

“Tecomet is a market leader with a true culture of excellence and a terrific management team,” said Mr. Swint. “Together we will leverage Tecomet’s key competitive strengths and build on its long track record of growth, while continuing to exceed the expectations of our customers and partners. Tecomet is well-positioned for future growth, and I look forward to leading the company to even greater success.”

Tecomet’s recent investments include the 3Q18 purchase of HD Surgical, a supplier of complex, high-precision surgical instruments. According to leadership, the acquisition was made primarily to support the instrument needs of the company’s mid-size customers. Also in 2018, Tecomet announced a series of investments ($14.5 million over the next three to five years) to upgrade and expand its Lansing, Michigan facilities, which manufacture hip and knee replacement implants and trauma plates, as well as grow its employee headcount by 160.

This email address is being protected from spambots. You need JavaScript enabled to view it., Editorial Assistant and Rob Meyer, Senior Editor, co-authored this report.